Welcome to our dedicated page for Life360 SEC filings (Ticker: LIFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Life360's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Life360's regulatory disclosures and financial reporting.
Life360, Inc. director Charles J. Prober received a grant of 4,455 shares of common stock in the form of Restricted Stock Units (RSUs) on May 29, 2026 as equity compensation. The RSUs carry no purchase price and each represents the right to receive one share upon settlement.
According to the terms, one-quarter of the RSUs will vest quarterly starting from May 15, 2026, subject to his continued service through each vesting date. Following this award, Prober directly holds 109,911 shares of Life360 common stock, which includes 5,134 RSUs that each convert into one share upon vesting.
Life360, Inc. director Charles J. Prober received a grant of 4,455 shares of common stock in the form of Restricted Stock Units (RSUs) on May 29, 2026 as equity compensation. The RSUs carry no purchase price and each represents the right to receive one share upon settlement.
According to the terms, one-quarter of the RSUs will vest quarterly starting from May 15, 2026, subject to his continued service through each vesting date. Following this award, Prober directly holds 109,911 shares of Life360 common stock, which includes 5,134 RSUs that each convert into one share upon vesting.
Life360, Inc. director Brit Morin received a grant of 4,636 Restricted Stock Units (RSUs), each representing a right to one share of common stock at no cash cost. One quarter of these RSUs will vest quarterly from May 15, 2026, assuming continued service. Following this award, Morin directly holds 30,630 shares and RSUs in total, which includes 5,345 RSUs that each convert into one share upon vesting.
Life360, Inc. director Brit Morin received a grant of 4,636 Restricted Stock Units (RSUs), each representing a right to one share of common stock at no cash cost. One quarter of these RSUs will vest quarterly from May 15, 2026, assuming continued service. Following this award, Morin directly holds 30,630 shares and RSUs in total, which includes 5,345 RSUs that each convert into one share upon vesting.
Life360, Inc. director Alex Haro received a grant of 4,455 Restricted Stock Units (RSUs), each representing a right to receive one share of common stock upon settlement. The award was made at a price of $0.00 per share as equity compensation.
According to the filing, one-quarter of the RSUs will vest quarterly from May 15, 2026, conditioned on Haro’s continued service through each vesting date. After this grant, he holds 1,010,303 shares of common stock, which includes 5,134 RSUs that will convert into shares upon vesting.
Life360, Inc. director Alex Haro received a grant of 4,455 Restricted Stock Units (RSUs), each representing a right to receive one share of common stock upon settlement. The award was made at a price of $0.00 per share as equity compensation.
According to the filing, one-quarter of the RSUs will vest quarterly from May 15, 2026, conditioned on Haro’s continued service through each vesting date. After this grant, he holds 1,010,303 shares of common stock, which includes 5,134 RSUs that will convert into shares upon vesting.
Goines Mark reported acquisition or exercise transactions in this Form 4 filing.
Life360, Inc. director Mark Goines reported an equity compensation award and updated share holdings. He received a grant of 5,322 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock upon settlement, with one‑quarter vesting quarterly from May 15, 2026, subject to his continuous service.
After this grant, he holds 11,392 shares of common stock directly, which include 6,102 RSUs. He also reports 56,809 shares held indirectly through the Goines Wong Living Trust. The transactions reflect routine stock-based compensation and updated ownership rather than open-market buying or selling.
Goines Mark reported acquisition or exercise transactions in this Form 4 filing.
Life360, Inc. director Mark Goines reported an equity compensation award and updated share holdings. He received a grant of 5,322 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock upon settlement, with one‑quarter vesting quarterly from May 15, 2026, subject to his continuous service.
After this grant, he holds 11,392 shares of common stock directly, which include 6,102 RSUs. He also reports 56,809 shares held indirectly through the Goines Wong Living Trust. The transactions reflect routine stock-based compensation and updated ownership rather than open-market buying or selling.
Life360, Inc. director John Philip Coghlan reported both equity awards and sales of common stock. He received a grant of 4,840 Restricted Stock Units at no cost, bringing his directly held RSUs to 5,676, which vest quarterly from May 15, 2026, subject to continued service. Through the John Coghlan Living Trust, he sold a total of 4,000 shares in open-market transactions at weighted average prices of about $43.95 and $44.64, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. After these sales, that trust holds 28,431 shares, while a separate Grantor Retained Annuity Trust holds 55,494 shares of common stock.
Life360, Inc. director John Philip Coghlan reported both equity awards and sales of common stock. He received a grant of 4,840 Restricted Stock Units at no cost, bringing his directly held RSUs to 5,676, which vest quarterly from May 15, 2026, subject to continued service. Through the John Coghlan Living Trust, he sold a total of 4,000 shares in open-market transactions at weighted average prices of about $43.95 and $44.64, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. After these sales, that trust holds 28,431 shares, while a separate Grantor Retained Annuity Trust holds 55,494 shares of common stock.
Life360 director Chris Hulls reported option exercises and share sales under a pre‑planned trading arrangement. On May 28, 2026, he exercised stock options for 27,000 shares of common stock at $8.19 per share and sold 16,379 shares in open‑market transactions at a weighted average price of $40.34 per share. The sale was executed pursuant to a Rule 10b5‑1 trading plan adopted in December 2025, meaning the trades followed predetermined criteria rather than discretionary timing.
After these transactions, the filing reports 419,864 shares of common stock held directly and 152,801 stock options remaining outstanding. It also shows 195,312 shares of common stock held indirectly in each of the McKenzie Hulls 2023 Irrevocable Trust, the Rose Hulls 2023 Irrevocable Trust, and the Robin Hulls 2023 Irrevocable Trust, along with 149,318 restricted stock units representing additional contingent rights to shares.
Life360 director Chris Hulls reported option exercises and share sales under a pre‑planned trading arrangement. On May 28, 2026, he exercised stock options for 27,000 shares of common stock at $8.19 per share and sold 16,379 shares in open‑market transactions at a weighted average price of $40.34 per share. The sale was executed pursuant to a Rule 10b5‑1 trading plan adopted in December 2025, meaning the trades followed predetermined criteria rather than discretionary timing.
After these transactions, the filing reports 419,864 shares of common stock held directly and 152,801 stock options remaining outstanding. It also shows 195,312 shares of common stock held indirectly in each of the McKenzie Hulls 2023 Irrevocable Trust, the Rose Hulls 2023 Irrevocable Trust, and the Robin Hulls 2023 Irrevocable Trust, along with 149,318 restricted stock units representing additional contingent rights to shares.
Life360, Inc. reported results of its annual stockholder meeting held on May 28, 2026. Stockholders representing 58,067,511 shares, or about 71.96% of the 80,689,686 shares outstanding as of April 9, 2026, were present, establishing a quorum.
Four Class I directors — Lauren Antonoff, Mark Goines, Alex Haro, and Randi Zuckerberg — were elected to serve until the 2029 annual meeting. Stockholders also approved, on an advisory and non-binding basis, the compensation of the named executive officers and ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026.
Life360, Inc. reported results of its annual stockholder meeting held on May 28, 2026. Stockholders representing 58,067,511 shares, or about 71.96% of the 80,689,686 shares outstanding as of April 9, 2026, were present, establishing a quorum.
Four Class I directors — Lauren Antonoff, Mark Goines, Alex Haro, and Randi Zuckerberg — were elected to serve until the 2029 annual meeting. Stockholders also approved, on an advisory and non-binding basis, the compensation of the named executive officers and ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026.
Christopher Hulls reported transactions in Common stock. The filing shows sales of $596,700.24 for 15,133 shares on 03/19/2026 and $732,962.71 for 16,105 shares on 04/16/2026. The filing also lists 16,379 shares of Common to be sold on 05/28/2026 related to an option granted on 05/20/2022, with cash listed as the payment method.
Christopher Hulls reported transactions in Common stock. The filing shows sales of $596,700.24 for 15,133 shares on 03/19/2026 and $732,962.71 for 16,105 shares on 04/16/2026. The filing also lists 16,379 shares of Common to be sold on 05/28/2026 related to an option granted on 05/20/2022, with cash listed as the payment method.
Life360, Inc. announced that its Board of Directors has authorized a new multi-year share repurchase program of up to $225 million of its outstanding common stock. The company may buy shares in the open market, through block trades, privately negotiated deals, or other permitted methods, including under Rule 10b5-1 plans and Rule 10b-18.
The program’s timing and amount of repurchases will be determined by management based on share price, market conditions, and the company’s liquidity needs, and it can be modified, suspended, or discontinued at any time. Life360 states that the objective is to offset dilution from stock-based compensation and notes support from a strong balance sheet and twelve consecutive quarters of positive operating cash flow.
Life360, Inc. announced that its Board of Directors has authorized a new multi-year share repurchase program of up to $225 million of its outstanding common stock. The company may buy shares in the open market, through block trades, privately negotiated deals, or other permitted methods, including under Rule 10b5-1 plans and Rule 10b-18.
The program’s timing and amount of repurchases will be determined by management based on share price, market conditions, and the company’s liquidity needs, and it can be modified, suspended, or discontinued at any time. Life360 states that the objective is to offset dilution from stock-based compensation and notes support from a strong balance sheet and twelve consecutive quarters of positive operating cash flow.
Life360, Inc. director Charles J. Prober exercised stock options and sold shares in a coordinated transaction. He exercised options for 7,930 shares of common stock at $11.18 per share and sold 7,930 shares at $40.44 per share in an open-market trade.
After these transactions, he directly holds 105,456 shares of common stock, which include 679 restricted stock units, and 47,580 stock options that remain outstanding and fully vested. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.
Life360, Inc. director Charles J. Prober exercised stock options and sold shares in a coordinated transaction. He exercised options for 7,930 shares of common stock at $11.18 per share and sold 7,930 shares at $40.44 per share in an open-market trade.
After these transactions, he directly holds 105,456 shares of common stock, which include 679 restricted stock units, and 47,580 stock options that remain outstanding and fully vested. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.